FDA.reportPublic FDA data

PENTOXIFYLLINE

Manufacturer
Sincerus Florida, LLC
Effective date
2019-05-08
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:28:38

Label at a glance#

ProductBETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5%
Active ingredientPENTOXIFYLLINE, BETAMETHASONE DIPROPIONATE, MINOXIDIL, NIACINAMIDE
Label structure4 sections

Label contents#

Full prescribing information#

Directions for use

INSTRUCTIONS FOR USE SECTION

sdsd

Sincerus Florida, LLC adverse reactions

ADVERSE REACTIONS SECTION

ww

Active, inactive

COMPONENTS

fafa

NDC 72934-4024-8 BETAMETHASONE DIPROPIONATE USP 0.05% / MINOXIDIL USP 5% / NIACINAMIDE USP 2% / PENTOXIFYLLINE USP 0.5%. Solution 60 gm

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ZCZC

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BETAMETHASONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
PENTOXIFYLLINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dde7b902-54a1-627e-12f1-9e6d244ab88cProduct name420250317
69b49899-11cf-4f7e-bd0a-7dc93b27311bProduct name320250130
bbdc14c7-d940-43b5-a2f7-36c425991f3cProduct name120240320
0a2fcc35-464b-9ec2-a622-753662cdd48cProduct name320240216
6f762601-17ef-4321-8f47-77783d3c4d8bProduct name320231116
1dbefad7-ab34-69c3-e51a-e7148aa38f70Product name520220921
7fea2046-07a9-4bb6-9409-828ac6f1f6dfProduct name120210201
f059f1a2-0e64-4839-9a7f-42687c91a44bProduct name120201007
4ea9e4b5-b452-48ad-9b25-b9a4d403405dProduct name120160310
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
06331747-0b00-4cea-707f-3d3bfb5d208dProduct name120140508
4f07db9b-3707-3e2c-05b5-d7852ba808c4Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-4024-82021-01-29C16284748780-1ba0f9c33-1cee-a910-e053-dadaa90a0b85BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-4024-8BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5%60 g in 1 BOTTLE, GLASSSOLUTION601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-4024BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5% SOLUTION [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190509_88612417-d10b-6a2b-e053-2995a90a7266.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72934-402472934-4024-8

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
PENTOXIFYLLINESD6QCT3TSUACTIB
BETAMETHASONE DIPROPIONATE826Y60901UACTIM
MINOXIDIL5965120SH1ACTIB
NIACINAMIDE25X51I8RD4ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
88612417-d10c-6a2b-e053-2995a90a726688612417-d10b-6a2b-e053-2995a90a72662019-05-08Adverse reactionsExact identifier
spl id: 88612417-d10c-6a2b-e053-2995a90a7266
spl set id: 88612417-d10b-6a2b-e053-2995a90a7266

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.